Abstract
AbstractUnderstanding the constraints that shape the evolution of antibiotic resistance is critical for predicting and controlling drug resistance. Despite its importance, however, a systematic investigation of evolutionary constraints is lacking. Here, we perform a high-throughput laboratory evolution ofEscherichia coliunder the addition of 95 antibacterial chemicals and quantified the transcriptome, resistance, and genomic profiles for the evolved strains. Utilizing machine learning techniques, we analyze the phenotype–genotype data and identified low dimensional phenotypic states among the evolved strains. Further analysis reveals the underlying biological processes responsible for these distinct states, leading to the identification of trade-off relationships associated with drug resistance. We also report a decelerated evolution of β-lactam resistance, a phenomenon experienced by certain strains under various stresses resulting in higher acquired resistance to β-lactams compared to strains directly selected by β-lactams. These findings bridge the genotypic, gene expression, and drug resistance gap, while contributing to a better understanding of evolutionary constraints for antibiotic resistance.
Funder
MEXT | Japan Society for the Promotion of Science
RIKEN SPDR Program
MEXT | JST | Exploratory Research for Advanced Technology
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference63 articles.
1. May, M. Drug development: time for teamwork. Nature 509, S4–S5 (2014).
2. O’Neill, J. Tackling drug-resistant infections globally: final report and recommendations. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (2016).
3. Suk, J. E., Vaughan, E. C., Cook, R. G. & Semenza, J. C. Natural disasters and infectious disease in Europe: a literature review to identify cascading risk pathways. Eur. J. Public Health 1–8. https://doi.org/10.1093/eurpub/ckz111 (2019).
4. Zhen, X., Lundborg, C. S., Sun, X., Hu, X. & Dong, H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob. Resist. Infect. Control 8, 137 (2019).
5. Harder, K. J., Nikaido, H. & Matsuhashi, M. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob. Agents Chemother. 20, 549–552 (1981).
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献